Monogenic diabetes mellitus hidden in autoantibody-negative diabetes mellitus

Parviainen, A., But, A., Siljander, H., Knip, M. & Finnish Pediatric Register. Decreased incidence of type 1 diabetes in young Finnish children. Diabetes Care 43, 2953–2958 (2020).

Article  Google Scholar 

Harsunen, M. T. et al. Identification of monogenic variants in more than ten per cent of children without type 1 diabetes-related autoantibodies at diagnosis in the Finnish Pediatric Diabetes Register. Diabetologia https://doi.org/10.1007/s00125-022-05834-y (2022).

Article  Google Scholar 

Carlsson, A. et al. Absence of islet autoantibodies and modestly raised glucose values at diabetes diagnosis should lead to testing for MODY: lessons from a 5-year pediatric Swedish national cohort study. Diabetes Care 43, 82–89 (2020).

Article  CAS  Google Scholar 

Sumnik, Z. et al. Five years of improving diabetes control in Czech children after the establishment of the population-based childhood diabetes register ČENDA. Pediatr. Diabetes 21, 77–87 (2020).

Article  CAS  Google Scholar 

Colclough, K., Ellard, S., Hattersley, A. & Patel, K. Syndromic monogenic diabetes genes should be tested in patients with a clinical suspicion of maturity-onset diabetes of the young. Diabetes 71, 530–537 (2022).

Article  CAS  Google Scholar 

Stankute, I. et al. Systematic genetic study of youth with diabetes in a single country reveals the prevalence of diabetes subtypes, novel candidate genes, and response to precision therapy. Diabetes 69, 1065–1071 (2020).

Article  CAS  Google Scholar 

Mirshahi, U. et al. Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts. Am. J. Hum. Genet. 109, 2018–2028 (2022).

Article  CAS  Google Scholar 

Pöllänen, P. M. et al. Autoantibodies to N-terminally truncated GAD65(96-585): HLA associations and predictive value for type 1 diabetes. J. Clin. Endocrinol. Metab. 107, e935–946 (2022).

Article  Google Scholar 

Food and Drug Administration. FDA approves first drug that can delay onset of type 1 diabetes. FDA.gov https://www.fda.gov/news-events/press-announcements/fda-approves-first-drug-can-delay-onset-type-1-diabetes (2022).

Chiarelli, F., Rewers, M. & Phillip, M. Screening of islet autoantibodies for children in the general population: a position statement endorsed by the European Society for Paediatric Endocrinology. Horm. Res. Paediatr. 95, 393–396 (2022).

Article  CAS  Google Scholar 

留言 (0)

沒有登入
gif